Drugs / HMPL-011
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03860532 Comparator | Sep → Dec 2011 | inflammatory bowel disease | Hutchison Medipharma Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HMPL-011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03860532 ↗ |
| Route | Oral | “A sigle total oral dose of 1200 mg tablets (600 mg tablet X 2)” NCT03860532 ↗ |